Modulation of rat liver citochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods

被引:14
作者
Cancino-Badías, L
Reyes, RE
Nosti, R
Pérez, I
Dorado, V
Caballero, S
Soria, A
Camacho-Carranza, R
Escobar, D
Espinosa-Aguirre, JJ
机构
[1] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico
[2] CIBIOMED, ICBP Victoria Giron, Havana, Cuba
[3] Inst Nacl Pediat, Mexico City 04530, DF, Mexico
关键词
D O I
10.1093/mutage/18.1.95
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Protein restriction (PR) significantly inhibits spontaneous and chemical carcinogenesis. Several factors seem to be involved in this effect, including a decrease in body weight, cellular proliferation and DNA damage and an increase in antioxidant defenses. The current study was designed to determine modifications in some hepatic cytochromes P450 (CYPs) due to a hypoproteic diet and to investigate its implications on chemical mutagenesis. Western blot analysis showed decreases of 73, 40 and 74% in CYP1A, CYP2B and CYP2E1 protein concentrations in hepatic microsomes from animals fed a protein-restricted (6% protein) diet for 6 weeks in comparison with microsomes from rats fed a 24% protein diet during the same period. In the same way, low protein fed animals showed a 3.5-fold decrease in hepatic CYP1A1-associated ethoxyresorufin O-deethylase activity, a 6-fold decrease in CYP1A2-associated methoxyresorufin O-demethylase activity, a 1.7-fold decrease in CYP2B1-associated penthoxyresorufin O-dealkylase activity, a 9-fold decrease in CYP2B2-associated benzyloxyresorufin O-dealkylase and, finally, a 3.4-fold decrease in CYP2E1-associated 4-nitrophenol hydroxylase activity. As a result of decreased CYP hepatic protein concentrations and enzymatic activities, liver S9 from rats fed a hypoproteic diet was less efficient in activating promutagens than S9 prepared from rats fed a 24% protein diet in the Ames test. Mutagenic potency obtained with protein-restricted S9 was reduced 25-fold for 2-aminoanthracene, 1.5-fold for N-nitrosodipropylamine, 12.5-fold for N-nitrosodibutylamine, 2-fold for cyclophosphamide and N-nitrosopyrrolidine and 71-fold for N-nitrosodimethylamine. However, the mutagenic potency of benzo[a]pyrene was the same (4 revertants/mug) with S9 derived from rats fed either a 6 or 24% protein diet.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 54 条
[1]   IDENTIFICATION OF HUMAN CYTOCHROMES-P-450 ANALOGOUS TO FORMS INDUCED BY PHENOBARBITAL AND 3-METHYLCHOLANTHRENE IN THE RAT [J].
ADAMS, DJ ;
SEILMAN, S ;
AMELIZAD, Z ;
OESCH, F ;
WOLF, CR .
BIOCHEMICAL JOURNAL, 1985, 232 (03) :869-876
[2]  
BADAWI AF, 1996, PROG CLIN BIOL RES, V395, P109
[3]  
BELL RC, 1990, FASEB J, V4, pA1043
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   ACETANILIDE PHARMACOKINETICS IN KWASHIORKOR [J].
BUCHANAN, N ;
DAVIS, MD ;
HENDERSON, DB ;
MUCKLOW, JC ;
RAWLINS, MD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (05) :525-526
[6]  
Burczynski ME, 1999, CANCER RES, V59, P607
[7]   EVALUATION OF PYRAZOLE AND ETHANOL-INDUCED S9 FRACTION IN BACTERIAL MUTAGENICITY TESTING [J].
BURKE, DA ;
WEDD, DJ ;
HERRIOTT, D ;
BAYLISS, MK ;
SPALDING, DJM ;
WILCOX, P .
MUTAGENESIS, 1994, 9 (01) :23-29
[8]   CYTOCHROME-P450 SPECIFICITIES OF ALKOXYRESORUFIN O-DEALKYLATION IN HUMAN AND RAT-LIVER [J].
BURKE, MD ;
THOMPSON, S ;
WEAVER, RJ ;
WOLF, CR ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (05) :923-936
[9]   ETHOXYPHENOXAZONES, PENTOXYPHENOXAZONES, AND BENZYLOXYPHENOXAZONES AND HOMOLOGS - A SERIES OF SUBSTRATES TO DISTINGUISH BETWEEN DIFFERENT INDUCED CYTOCHROMES-P-450 [J].
BURKE, MD ;
THOMPSON, S ;
ELCOMBE, CR ;
HALPERT, J ;
HAAPARANTA, T ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) :3337-3345
[10]  
CHANG TKH, 1993, CANCER RES, V53, P5629